TRELLIS BIOSCIENCE, INC.

Harnessing the Human Immune System

Redwood City, United States · Founded 2015 · $19.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$19.0M
Last Round
$9.0M Series CJul 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 2 investors for this company. The full record is or through the API.

About

Trellis Bioscience is a clinical-stage biotechnology company that uses its proprietary CellSpot™ technology to discover rare, naturally optimized human monoclonal antibodies from healthy donor blood. The company targets infectious diseases and cancer with therapeutics that are safer and more effective due to their human origin. Trellis has derived five mAb therapeutic candidates with demonstrated superior binding affinity and broad-spectrum capabilities.

Summary

TRELLIS BIOSCIENCE, INC. is a Biotech company based in Redwood City, United States, founded in 2015. It has raised $19.0M in total across 4 rounds, most recently a $9.0M Series C round in Jul 2026. Investors include CARB-X and National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJul 2026
$9.0M

Sign up to see all 4 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TRELLIS BIOSCIENCE, INC. on Indexed.vc
<a href="https://indexed.vc/companies/trellis-bioscience-inc"><img src="https://indexed.vc/api/badge/company/trellis-bioscience-inc" alt="TRELLIS BIOSCIENCE, INC. on Indexed.vc" width="260" height="76" /></a>